– Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock potential for new breakthrough treatments – – Landmark research project is 100x larger than existing efforts – – Data will be generated from thousands of patients across multiple cancers – – University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, […]
ERS Genomics & abm enter into CRISPR/Cas9 Licensing Agreement This License allows abm to develop and commercialize products using CRISPR/Cas9 technology. Dublin, Ireland and Vancouver, Canada, 1st June 2023: ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Applied Biological Materials Inc (‘abm,’). This is a non-exclusive licensing agreement granting abm access to the ERS CRISPR/Cas9 […]
MUNICH, Germany and TEL AVIV, Israel — NurExone Biologic Inc. (the “Company” or “NurExone”) NRX (FSE: J90), a biopharmaceutical company developing biologically-guided exosome therapy (“ExoTherapy”) for patients with traumatic spinal cord injuries, is pleased to announce a pioneering collaboration with the German company, Particle Metrix, a leading provider of particle analysis devices. In connection with […]
The companies agree to a worldwide Human Platelet Lysate (HPL) Patent License and Assignment Agreement, including redirection of HPL customers from Macopharma to PL BioScience. AACHEN, Germany — PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, today announced a Patent License […]
NANJING, China — Vazyme (688105.SH), China’s leading biotechnology company, has officially signed a global strategic cooperation agreement with Azenta Life Sciences (“Azenta”, Nasdaq: AZTA), which will promote to establish “one-stop” service process for both companies in the fields of next-generation sequencing, automated library preparation, raw material supply, experimental consumables, sample storage and more. Dr. Nie Junwei, General Manager of […]
RNA fusions can be used as biomarkers to identify cancer sub-types and monitor for residual disease SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and CeGaT GmbH, a global provider of sequencing services for research, clinical studies, and […]
WATERTOWN, Mass. — Fluent BioSciences, a life science tools company, delivering single-cell technology to laboratories across the United States and abroad, collaborates with Genspace by sponsoring a community science workshop in Brooklyn, NY. They hope to empower scientists by breaking down barriers in a field which has previously been marred by prohibitive costs and expertise requirements. At Genspace, their […]
CHADDS FORD, Pa. — MOBILion Systems Inc . today announced a joint project to be conducted with the U.S. Environmental Protection Agency (EPA) aimed at developing analytical methods for the addition of high-resolution ion-mobility into existing Per- and Polyfluoralkyl (PFAS) non-targeted analysis (NTA) high-resolution mass spectrometry (investigations at the EPA laboratory in Research Triangle Park North Carolina). EPA will […]
Collaboration to enhance BRIN’s scientific and innovation infrastructure and talent SINGAPORE — Thermo Fisher, the world leader in serving science, has signed a Memorandum of Understanding (“MOU”) with the National Research and Innovation Agency of Indonesia (BRIN, Badan Riset dan Inovasi Nasional) to enable and enhance the country’s national research and innovation infrastructure and capability. […]
On March 20, Shimadzu Corporation signed an agreement with Osaka University with the aim of improving their scientific and technical capabilities, developing human resources, and contributing to society through industry-academia collaboration. Shimadzu is launching the REACH Project*1 to develop and recruit highly specialized, global human resources. (From left) Osaka University Executive Vice President Tanaka Toshihiro, Osaka […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
